This page describes pharmacological agents that may have legal restrictions, side effects, and drug interactions in your jurisdiction. Information is for educational research only — consult a clinician before considering any compound.
Vitamin C
Cheap, essential, broadly useful — but the supplementation benefit in a fed-state young athlete is modest at 200-500 mg/day.
Aliases (1)
Overview
What is Vitamin C?
Cheap, essential, broadly useful — but the supplementation benefit in a fed-state young athlete is modest at 200-500 mg/day. The two non-redundant use cases for Dylan: (1) 500 mg + 15 g gelatin/collagen, 30-60 min before tendon/ligament rehab work (Shaw 2017 protocol, replicated Lis & Baar 2019, Praet 2021) — directly relevant to MMA tendon/ligament load and to the collagen-peptides line in V4; (2) 200-500 mg/day during heavy training blocks and cold-weather camps — Hemilä Cochrane 2013 showed ~50% URTI risk reduction in athletes and cold-exposed populations vs. negligible in general population. Outside those windows, food sources (citrus, peppers, kiwi, berries) cover RDA at zero cost. Don't mega-dose chronically (>1 g/day around training) — Ristow 2009 and Paulsen 2014 show >1 g/day with vitamin E blunts mitochondrial adaptation to endurance training. Saturation pharmacokinetics (Levine 1996, PMID 8623000) mean single doses >500 mg waste most of the additional vitamin.
Peptide Interactions
Vitamin C regenerates the oxidized α-tocopheroxyl radical, allowing vitamin E to keep recycling at the lipid membrane interface. Classic combination. Caveat:…
100 mg vit C with plant-iron meal doubles absorption. Time them together. Don't take with heme iron sources (no enhancement, may exaggerate iron overload risk).
Vit C regenerates oxidized glutathione (GSSG → GSH), and GSH regenerates dehydroascorbate. Cooperative cycling. NAC provides cysteine precursor for GSH synth…
15 g collagen + 500 mg vitamin C 30-60 min pre-exercise — the strongest evidence-backed athletic-application stack for vit C. This is the targeted Dylan use …
Synergistic antioxidant effect demonstrated in cell + animal models; modest human translation. Whole-food sources cover this naturally.
Common cold lozenges combine zinc + vit C with modest additive duration-reduction effect.
No direct mechanistic synergy but co-supplementation is the standard "immune stack" — both improve respiratory infection resilience independently.
see training-blunting evidence above.
vitamin C may interfere with some chemotherapy via antioxidant mechanism. Coordinate with oncology if relevant.
theoretical interaction via acidified urine reducing renal clearance; clinically minor.
cumulative iron load risk.
What to Expect
- Week 1Tolerability and dose-response.
- Week 2-4Early effect window.
- Week 4-8Peak benefit assessment.
- Week 8+Cycle decision point.
Side Effects & Safety 6
Side Effects
- 1GI upset / osmotic diarrhea at >2 g/day or single doses >1 g, particularly on empty stomach. Buffered forms (calcium/sodium ascorbate, Ester-C) reduce GI burden. Time-release helps modestly.
- 2Mild nausea, abdominal cramps at similar doses.
- 3Mild headache — usually associated with rapid IV infusion or very high oral bolus, not chronic supplementation.
- 4Increased flatulence.
- 5Heartburn (ascorbic acid is, well, acidic; buffered forms eliminate this).
- 6Transient erythrocyte hemolysis in G6PD-deficient individuals at IV high dose — see below.
When to Stop
- Calcium oxalate kidney stones at chronic doses >1 g/day in oxalate-prone individuals. Ascorbate → oxalate is a real metabolic route, modest in normal individuals but meaningful in stone-formers. Multiple cohort studies (Nurses' Health, Physicians' Health) show ~40-50% higher stone risk in men taking ≥1 g/d vit C chronically. Mitigation: keep doses ≤500 mg/d if stone history; ensure 2-3 L/day fluid intake; consider potassium citrate co-supplementation if stone-forming with vitamin C.
- G6PD deficiency + acute hemolysis with high-dose IV vitamin C. Mechanism: ascorbate at millimolar concentrations generates H2O2; G6PD-deficient erythrocytes lack glutathione regeneration to neutralize it. Oral doses ≤2 g/d are generally tolerated; IV requires G6PD screening.
- Iron overload exacerbation in hemochromatosis. Vitamin C enhances iron absorption (Fe3+ → Fe2+) and also mobilizes iron from ferritin. In HFE C282Y/C282Y or H63D hemochromatosis, chronic high-dose vit C can accelerate hepatic iron loading. Mitigation: screen ferritin + TIBC + transferrin saturation if family history of liver disease; if hemochromatosis confirmed, avoid >RDA dose and never co-administer with iron-containing meals.
- Lab test interference. Vitamin C at chronic high dose interferes with: fecal occult blood (false negative — important if screening for colon cancer), urine glucose strips (false negative), urine ketone strips, vitamin B12 assays (some methods), and capillary glucose meters (some methods). Stop high-dose ≥48 h before scheduled labs.
- No specific onset window — vitamin C is exceptionally safe and most adverse signals are dose-dependent rather than time-dependent.
- Kidney stones develop over months-years; not an acute concern but a chronic watch in stone-formers.
- G6PD-related hemolysis is acute — IV use only, screen first.
References
Levine et al. 1996 PNAS — Vitamin C pharmacokinetics in healthy volunteers (PMID 8623000)
foundational pharmacokinetic paper establishing saturation kinetics, 200 mg single-dose bioavailability, and the basis for the 200 mg/d Linus Pauling Institute recommendation.
View StudyHemilä & Chalker 2013 Cochrane — Vitamin C for preventing and treating the common cold (PMID 23440782)
definitive systematic review; 8% adult / 14% pediatric duration reduction with regular supplementation; ~50% incidence reduction in athletes/cold-exposed subgroup (5 trials, n=598).
View StudyShaw et al. 2017 Am J Clin Nutr — Vitamin C-enriched gelatin + collagen synthesis (PMID 27852613)
the foundational athletic-application paper; 15 g gelatin + vit C pre-exercise doubled P1NP at 4 hr.
View StudyLis & Baar 2019 Int J Sport Nutr Exerc Metab — Different vitamin C-enriched collagen derivatives on collagen synthesis (PMID 30859848)
confirmed both gelatin and hydrolyzed collagen + vit C work equivalently.
View StudyPraet et al. 2021 — Collagen + vitamin C × 3 months improves lower-limb rate of force development (PMID 34808597)
longest-duration outcome study supporting Shaw protocol's functional translation.
View StudyPaulsen et al. 2014 J Physiol — Vitamin C + E supplementation hampers cellular adaptation to endurance training (PMID 24492839)
11-week RCT showing blunted mitochondrial markers at 1 g vit C + 235 mg vit E daily.
View StudyRistow et al. 2009 PNAS — Antioxidants prevent health-promoting effects of physical exercise in humans (PMID 19433800)
the original mitohormesis paper; 1 g vit C + 400 IU vit E blocked exercise-induced insulin sensitivity gains.
View StudyCarr & Maggini 2017 Nutrients — Vitamin C and Immune Function (PMID 29099763)
comprehensive review of immune cell biology and supplementation evidence.
View StudyDavis et al. 2016 Nutr Metab Insights — Liposomal-encapsulated ascorbic acid bioavailability (PMID 27375360)
the only properly controlled liposomal vs plain comparison; 1.4× AUC at 4 g dose.
View StudyVitamin C severity meta-analysis 2023 (PMID 38082300)
updated meta confirming Hemilä findings on cold severity and duration.
View StudyHigashida et al. 2011 Am J Physiol Endocrinol Metab — Normal adaptations to exercise despite protection against oxidative stress (PMID 21750271)
counterpoint to Ristow/Paulsen; preserved mitochondrial biogenesis at high antioxidant dose in rat model.
View StudyLinus Pauling Institute Vitamin C monograph (Oregon State)
comprehensive evidence summary with the institute's 200 mg/d recommendation.
View StudyNIH Office of Dietary Supplements — Vitamin C Fact Sheet for Health Professionals
authoritative US government summary.
View StudyLOVIT trial — Lamontagne et al. 2022 NEJM — Intravenous vitamin C in adults with sepsis in the ICU
the trial that ended the vit C in sepsis enthusiasm.
View StudyComparative effectiveness of oral nutritional supplements in preventing respiratory tract infections — network meta-analysis 2024
recent network meta confirming vit C's place in the respiratory-prevention supplement landscape.
View StudyLatest research
- meta-analysisComparative effectiveness of oral nutritional supplements in preventing respiratory tract infections among adultsNetwork meta-analysis; vitamin C among supplements with credible URTI-prevention signal, strongest in athletic and high-exertion subgroups.
- metaVitamin C reduces the severity of common colds — meta-analysisUpdated 2023 meta confirms Cochrane finding — modest reduction in cold duration and severity with regular daily supplementation; no incidence reduction in general population.
- rctCollagen + vitamin C supplementation increases lower-limb rate of force development15 g collagen + 50 mg vit C × 3 months improved RFD and tendon stiffness in male athletes — extends Shaw 2017 protocol with longer-duration outcome data.
How was your experience with this compound?
Anonymous · one vote per session · results below at 5+ votes.
See something off?
Most of this wiki is AI-generated. Suggest a correction, dosing update, or new evidence — we review every submission.